Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2024

SuperCom Ltd. (NASDAQ: SPCB) Reports Growth in Recurring Revenues, including Inking of New EM Contracts with West Virginia Law Enforcement Agencies

Posted on September 4, 2024 by MissionIR

Electronic monitoring (“EM”) and identification security solutions developer SuperCom (NASDAQ: SPCB) is increasing its recurrent contract revenue with the recent signing of agreements with multiple sheriff agencies throughout West Virginia for its monitoring technology. The sheriffs’ offices in each of the state’s … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Additional Orders from European Governments Totaling $2.6M

Posted on September 3, 2024 by MissionIR

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has received new orders valued at $2.6 million from different governments in Europe; the company anticipates fulfilling the orders in the next three months. … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology in Pre-Clinical Setting

Posted on September 3, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company. Under the terms of the agreement, the pharmaceutical company will evaluate Lexaria’s DehydraTECH(TM) technology in a pre-clinical … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Management to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Posted on September 3, 2024 by MissionIR

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Extends Quantum AI Product Roadmap, Quantum Cloud Service Enhancements Featured in Syndicated Broadcast

Posted on September 3, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, was featured in a NetworkNewsAudio syndicated broadcast highlighting the company’s extended quantum AI product roadmap and enhancements to its … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment